# Lantern Pharma Inc. (LTRN) — capital_raise/atm_program [announced]
Source: sec.gov · situation sit_377125e205faa9ab7fb3 · public 8844906097577661419 · retrieved 2026-08-19T11:37:54.147Z

## Overview
Lantern Pharma Inc. is an AI-driven clinical-stage precision oncology company leveraging its proprietary RADR artificial intelligence and machine learning platform to transform the cost, pace, and timeline of oncology drug discovery and development.

Lantern Pharma Inc. announced in August 2026 the formal creation of Open Medicine AI (OMAI) as a separate company with board-approved commercial licensing agreements executed between OMAI and Lantern Pharma. OMAI licenses Lantern's AI models, data, algorithms, and related assets and personnel to operate the multi-agentic AI co-scientist platform previously launched as withZeta.ai. OMAI is currently 100% owned by Lantern Pharma and intends to raise capital in exchange for equity. The longer-term objective is for OMAI to become a newly listed company on a national stock exchange or market, with Lantern expecting to remain one of OMAI's largest shareholders.

## Terms
- Stake: 100%

## Key dates
- Announced 2026-08-14

## Timeline
- 2026-08-14 · 8-K (0001493152-26-037979): 8-K - Lantern Pharma Inc. — *Lantern Pharma Inc. is an AI-driven clinical-stage precision oncology company leveraging its proprietary RADR artificial intelligence and machine learning platform to transform the cost, pace, and timeline of oncology drug discovery and development.* Lantern Pharma Inc. announced in August 2026 the formal creation of Open Medicine AI (OMAI) as a separate company with board-approved commercial licensing agreements executed between OMAI and Lantern Pharma. OMAI licenses Lantern's AI models, data, algorithms, and related assets and personnel to operate the multi-agentic AI co-scientist platform previously launched as withZeta.ai. OMAI is currently 100% owned by Lantern Pharma and intends to raise capital in exchange for equity. The longer-term objective is for OMAI to become a newly listed company on a national stock exchange or market, with Lantern expecting to remain one of OMAI's largest shareholders.
  https://www.sec.gov/Archives/edgar/data/1763950/0001493152-26-037979.txt

## Citations
- 0001493152-26-037979 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226037979